All Stories

  1. Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types
  2. Cottontail Rabbit Papillomavirus E1 and E2 Proteins Mutually Influence Their Subcellular Localizations
  3. Vaginal prevalence of human papillomavirus infections in women with uterovaginal aplasia before and after laparoscopically assisted creation of a neovagina: a prospective epidemiological observational study
  4. Sexual inactivity and occurrence of STIs in relation to weight status in women: Two large population-based studies
  5. RNA sequencing analysis identifies novel spliced transcripts but does not indicate quantitative or qualitative changes of viral transcripts during progression of cottontail rabbit papillomavirus-induced tumours
  6. Human Papillomavirus Infection Among 2460 Men in Denmark
  7. Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization
  8. clinical performance of the RNA based Aptima HPV test
  9. Characterization of the Human Papillomavirus 16 E8 Promoter
  10. Role of human papillomavirus testing and cytology in follow-up after conization
  11. Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology
  12. A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off
  13. Detection of mutation-specific epidermal growth factor receptor (E746–A750del) and lack of detection of human papillomavirus in oral squamous cell carcinoma
  14. WOLVES – Genotypenspezifisches Modell der HPV-Clearance und -Persistenz bei jungen Frauen in Wolfsburg
  15. Detection of oncogenic genital human papillomavirus (HPV) among HPV negative older and younger women after 7 years of follow-up
  16. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women
  17. Filaggrin, Human Papillomavirus, and the Cervix
  18. A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion
  19. High-Risk and Low-Risk Human Papillomavirus and the Absolute Risk of Cervical Intraepithelial Neoplasia or Cancer
  20. Persistence and reappearance of high-risk human papillomavirus after conization
  21. Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?
  22. The Viral E8^E2C Repressor Limits Productive Replication of Human Papillomavirus 16
  23. Human papillomaviruses and cancer
  24. Risk Factors for High-Risk Human Papillomavirus Detection Among HIV-Negative and HIV-Positive Women From Tanzania
  25. Annual Papanicolaou screening for 5 years among human papillomavirus-negative women
  26. Vemurafenib (PLX-4032)-induced keratoses: Verrucous but not verrucae
  27. Papillomvireninfektion und Tumorigenese
  28. Prevalence and Type Distribution of Human Papillomavirus Among 1813 Men in Tanzania and the Relationship to HIV Status
  29. Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84 – results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany
  30. Cell-type-dependent activities of regulatory regions and E2 proteins derived from carcinogenic and non-carcinogenic human alphapapillomaviruses
  31. Früherkennung. Kategorisierung von HPV-Tests
  32. A recombinant cottontail rabbit papillomavirus genome for ectopic expression of genes in cells infected with virus in vivo
  33. Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany
  34. Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania
  35. Nucleic Acid Tests for the Detection of Alpha Human Papillomaviruses
  36. Papillomvireninfektion und Tumorigenese
  37. Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
  38. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study
  39. Human Papillomavirus Prevalence and Type Distribution in 3603 HIV-Positive and HIV-Negative Women in the General Population of Tanzania
  40. Papillomviren und Polyomaviren
  41. Regulation of Na+-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein
  42. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: An epidemiological observational study
  43. Interaction of the Papillomavirus E8∧E2C Protein with the Cellular CHD6 Protein Contributes to Transcriptional Repression
  44. p38γ MAPK Cooperates with c-Jun in trans -Activating Matrix Metalloproteinase 9
  45. NCoR1 Mediates Papillomavirus E8^E2C Transcriptional Repression
  46. Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women
  47. Evaluation of the performance of the novel PapilloCheck® HPV genotyping test by comparison with two other genotyping systems and the HC2 test
  48. Kanzerogenese durch Viren
  49. Acquisition of High-Risk Human Papillomavirus Infection in a Population-Based Cohort of Danish Women
  50. O418 Smoking among HPV positive women - a risk factor for subsequent cervical lesions
  51. Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes
  52. Onkologie. Informationskampagne ZERVITA zum Thema Gebärmutterhalskrebs-Früherkennung und Prävention
  53. Übersicht – Epidemiologie, Ätiologie und Prävention des Zervixkarzinoms
  54. AP-1 and ERK1 but not p38 nor JNK is required for CRPV early protein 2-dependent MMP-9 promoter activation in rabbit epithelial cells
  55. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark
  56. New Technologies in Cervical Cancer Screening
  57. Inhibition of Transcription and DNA Replication by the Papillomavirus E8⁁E2C Protein Is Mediated by Interaction with Corepressor Molecules
  58. The E7 protein of the cottontail rabbit papillomavirus immortalizes normal rabbit keratinocytes and reduces pRb levels, while E6 cooperates in immortalization but neither degrades p53 nor binds E6AP
  59. Type-Specific HPV Infection and Multiple HPV Types: Prevalence and Risk Factor Profile in Nearly 12,000 Younger and Older Danish Women
  60. A novel splice donor site at nt 1534 is required for long-term maintenance of HPV31 genomes
  61. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types
  62. Isolation and functional analysis of five HPVE6 variants with respect to p53 degradation
  63. Classification of the Papillomaviruses-Mapping the Genome
  64. Cutaneous Human Papillomaviruses Found in Sun‐Exposed Skin: Beta‐papillomavirus Species 2 Predominates in Squamous Cell Carcinoma
  65. Onkologie. Stellenwert der HPV-Vakzine
  66. HPV-Infektion und Zervixkarzinom - eine Übersicht
  67. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance
  68. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins
  69. Changes of epidermodysplasia verruciformis in benign skin lesions: the EV acanthoma
  70. Population-based study of screening test performance indices of three human papillomavirus DNA tests
  71. Prevalence of human papillomavirus types in women screened by cytology in Germany
  72. Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes
  73. Jugendsexualität. Aufklärung und Prävention in der Jugendgynäkologie - Eine Aufgabe für die Frauenärztin/-arzt
  74. Onkologie. Zervixkarzinom: Chancen und Risiken des Früherkennungsprogramms
  75. The human papillomavirus
  76. Overview of the European and North American studies on HPV testing in primary cervical cancer screening
  77. Kanzerogenese durch Viren
  78. The Papillomavirus E8∧E2C Protein Represses DNA Replication from Extrachromosomal Origins
  79. Economic evaluation of human papillomavirus screening in Germany
  80. Chapter 12: Human Papillomavirus Technologies
  81. A Transactivator Function of Cottontail Rabbit Papillomavirus E2 Is Essential for Tumor Induction in Rabbits
  82. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1
  83. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia
  84. Current methods of testing for human papillomavirus
  85. The E8 Domain Confers a Novel Long-Distance Transcriptional Repression Activity on the E8^E2C Protein of High-Risk Human Papillomavirus Type 31
  86. Synthesis of Viral DNA and Late Capsid Protein L1 in Parabasal Spinous Cell Layers of Naturally Occurring Benign Warts Infected with Human Papillomavirus Type 1
  87. Human Papillomavirus Testing in Primary Screening for Cervical Cancer of Human Immunodeficiency Virus-Infected Women, 1990–1998
  88. Induction of E6/E7 Expression in Cottontail Rabbit Papillomavirus Latency Following UV Activation
  89. Expression of the E6 and E7 Genes of Human Papillomaviruses in Tumors of Different Dignity
  90. The predominant mRNA class in HPV16-infected genital neoplasias does not encode the e6 or the E7 protein
  91. Human papillomavirus type 6 in squamous cell carcinoma of the bladder and cervix
  92. The E7 protein of human papillomavirus 8 Is a nonphosphorylated protein of 17 kDa and can be generated by two different mechanisms
  93. Two Independently Transforming Functions of Human Papillomavirus 8
  94. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells
  95. Molecular Basis of Cervical Neoplasia